Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 22, 2025 • 5:00 AM ET

Date/Time Source News Release
03/17/2025 08:05 AM EDT Business Wire Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society International Conference 2025
03/06/2025 08:05 AM EST Business Wire Savara Announces U.S. Launch of the aPAP ClearPath(TM) Dried Blood Spot Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
10/01/2024 08:05 AM EDT Business Wire Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
09/27/2024 04:05 PM EDT Business Wire Savara Announces New Employment Inducement Grant
09/27/2024 08:05 AM EDT Business Wire Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
09/24/2024 08:05 AM EDT Business Wire Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately
09/23/2024 08:05 AM EDT Business Wire Savara to Host Analyst and Investor Webinar on September 30, 2024
09/08/2024 06:45 AM EDT Business Wire Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024
09/06/2024 04:05 PM EDT Business Wire Savara Announces New Employment Inducement Grant
09/03/2024 04:05 PM EDT Business Wire Savara to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Page

Additional News

As of June 22, 2025 • 5:00 AM ET

Date/Time Source News Release
05/30/2025 11:15 AM EDT ACCESS Newswire IA Did Savara Inc. (SVRA) Mislead Investors? Levi & Korsinsky Investigates
05/30/2025 07:30 AM EDT ACCESS Newswire IA Levi & Korsinsky Announces an Investigation on Behalf of Savara Inc. (SVRA) Shareholders Who May Have Been Affected by Fraud
03/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 13th, 2025
03/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Savara Inc.
03/06/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, March 6th, 2025
03/06/2025 04:31 AM EST US Earnings Reports Expected earnings - Savara Inc.
09/24/2024 08:21 AM EDT SeekingAlpha Savara appoints Braden Parker as chief commercial officer
09/09/2024 06:32 PM EDT SeekingAlpha Savara: Trial Successful, But I'm Only Half Convinced
08/13/2024 07:15 AM EDT KlickAnalytics Outperform Recommendation Issued On SVRA By JMP Securities
08/13/2024 07:00 AM EDT KlickAnalytics SVRA Price Target Alert: $9.00. Issued by JMP Securities
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.